Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 25.3B | 28.9B | 23.1B | 22.1B |
Cost of revenue | 4.5B | 24.9B | 4.4B | 4.3B |
Gross profit | 20.7B | 4.0B | 18.7B | 17.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.0B | -4.4B | 3.1B | 2.7B |
Operating income | 20.2B | -4.8B | 16.2B | 15.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 14.9B | -9.0B | 13.6B | 13.1B |
Other income expense | — | — | — | — |
Pretax income | 3.0B | 1.2B | 906.9M | 1.9B |
Tax provision | 246.6M | 136.3M | 521.3M | 272.3M |
Net income | 2.8B | 1.0B | 385.6M | 1.6B |
Basic EPS | 12.2 | — | 1.7 | 7.2 |
Diluted EPS | 12.1 | — | 1.7 | 7.2 |
Basic average shares | 226.2M | — | 225.5M | 225.4M |
Diluted average shares | 227.8M | — | 228.2M | 227.9M |
EBITDA | 22.4B | -762.4M | 17.6B | 17.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |